The McGill community, including researchers in genomic medicine and the health sciences, came together in July 2024 to mark the next phase of one of the University’s most rapidly growing...
Discover how lipid nanoparticles are transforming gene therapy in a new article co-authored by Pieter Cullis, Professor, Biochemistry and Molecular Biology at The University of British Columbia.
Join D2R for a virtual webinar where we delve into the forefront of Ï㽶ÊÓƵ and genomics research with experts from McGill and UBC./dna-to-rnaCategory: Research and innovation
In a press release published by the Global Alliance for Genomics and Health (GA4GH), it was announced that the Victor Phillip Dahdaleh Institute of Genomic Medicine at Ï㽶ÊÓƵ has joined...
On June 11, 2024 CQDM announced the creation of the Ï㽶ÊÓƵ Therapy Development and Production Network, which will offer Ï㽶ÊÓƵ therapy biomanufacturing services to academic and industrial researchers.
Imagine a world where your unique genetic makeup can be used to tailor your medical care, and where illnesses and disease are treated with pinpoint accuracy....
The McGill Regenerative Medicine Network (MRM) and Canadian Advanced Therapies Training Institute (CATTI) are pleased to announce a call for trainee submission
As part of the Distinguished Professors Lecture Series by RI-MUHC, Professor Sir Paul Nurse, Chief Executive Officer of The Francis Crick Institute and Nobel Laureate in Physiology or Medicine will...